HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oxytocin in the regulation of social behaviours in medial amygdala-lesioned mice via the inhibition of the extracellular signal-regulated kinase signalling pathway.

Abstract
The neuropeptide oxytocin (OXT) has been implicated in the pathophysiology of behavioural deficits among patients with autism spectrum disorder (ASD). However, the molecular mechanisms underlying its role in ASD remain unclear. In the present study, a murine model with ASD-like phenotypes was induced by intra-medial amygdala injection of N-methyl-d-aspartate, and it was used to investigate the role of OXT in behaviour regulation. Behavioural tests were performed to verify the ASD-like phenotypes of N-methyl-d-aspartate-treated mice, and the results showed that mice with bilateral medial amygdala lesions presented significant behavioural deficits, including impaired learning and memory and increased anxiety and depression. We also observed a notably decreased level of OXT in both the plasma and the hypothalamus of medial amygdala-lesioned mice, and the extracellular signal-regulated kinase (ERK) was activated. Further studies demonstrated that the administration of OXT alleviated ASD-like symptoms and significantly inhibited phosphorylation of ERK; the inhibitory effect was similar to that of U0126, an ERK signalling inhibitor. In addition, OXT administration modulated the expression of downstream proteins of the ERK signalling pathway, such as cyclic adenosine monophosphate response element binding and c-fos. Taken together, our data indicate that OXT plays an important role in ameliorating behavioural deficits in an ASD-like mouse model, which was mediated by inhibiting the ERK signalling pathway and its downstream proteins.
AuthorsYu Wang, Shanshan Zhao, Zhe Wu, Yu Feng, Chuansheng Zhao, Chaodong Zhang
JournalClinical and experimental pharmacology & physiology (Clin Exp Pharmacol Physiol) Vol. 42 Issue 5 Pg. 465-74 (May 2015) ISSN: 1440-1681 [Electronic] Australia
PMID25707920 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 Wiley Publishing Asia Pty Ltd.
Chemical References
  • Cyclic AMP Response Element-Binding Protein
  • Nerve Tissue Proteins
  • Proto-Oncogene Proteins c-fos
  • Shank2 protein, mouse
  • Oxytocin
  • N-Methylaspartate
  • Extracellular Signal-Regulated MAP Kinases
Topics
  • Amygdala (drug effects, metabolism, pathology)
  • Animals
  • Autism Spectrum Disorder (psychology)
  • Behavior, Animal (drug effects)
  • Cell Count
  • Cyclic AMP Response Element-Binding Protein (metabolism)
  • Down-Regulation (drug effects)
  • Enzyme Activation (drug effects)
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Hypothalamus (metabolism)
  • MAP Kinase Signaling System (drug effects)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • N-Methylaspartate (adverse effects)
  • Nerve Tissue Proteins (metabolism)
  • Neurons (drug effects, pathology)
  • Oxytocin (blood, metabolism, pharmacology)
  • Phenotype
  • Proto-Oncogene Proteins c-fos (metabolism)
  • Social Behavior
  • Up-Regulation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: